AVXS-1-1

Biogen faces increased 'pressure' after AveXis buyout by Novartis
Marketwatch
Mon, 04/9/18 - 09:10 am
Novartis
AveXis
Biogen
SMA
M&A
AVXS-1-1
Spinraza